Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

I-Mab Biopharma

www.i-mabbiopharma.com

Latest From I-Mab Biopharma

Start-Up Quarterly Statistics: Financings Fell 17% To $2.84bn In Q2

A review of second quarter biopharma start-up deal-making and financing activity from Strategic Transactions showed a quarter-over-quarter drop in dollars raised despite multiple mega-rounds, including $100m-plus VC deals for SpringWorks and Fusion.

Deals Financing

Deal Watch: Genentech Inks New Collaborations With Skyhawk, Convelo

Skyhawk continues its recent spate of deal-making, using its SkyStar platform in a deal with Genentech, which also is looking into neurology with Convelo. AbbVie buys STING specialist Mavupharma, while Recordati pays Novartis $390m for Cushing’s products.

Deals Business Strategies

Shaken MorphoSys ‘Assessing Options’ After Losing US Darzalex Patent Ruling

But German Biotech says court summary judgement will have no bearing on MorphoSys's own CD38 antibody MOR202.

Legal Issues Platform Technologies

Follow The Money, An Interactive Biotech Financing Map

In 2018, while biotech venture activity spoke mainly with an American accent, China emerged as the world’s third most active cluster, while the UK led the way in Europe.

Commercial Financing
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • I-Mab Biopharma
  • Senior Management
  • Jingwu Zang, MD, PhD, CEO
    Jielun Zhu, CFO
    Weimin Tang, PhD, EVP, Global Bus. Dev.
    Joan Huaqiong Shen, MD, PhD, Pres., R&D
  • Contact Info
  • I-Mab Biopharma
    Phone: 21 6057 8000
    Ste. 802, West Tower, 88 Shangke Rd.
    Pudong District
    Shanghai, 201210
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register